Month: July 2020

BOLTON, Ontario, July 14, 2020 (GLOBE NEWSWIRE) — Titanium Transportation Group Inc. (“Titanium” or the “Company”) (TSX VENTURE:TTR) is pleased to announce that it recently opened its second U.S. Freight Brokerage office in Nashville, Tennessee, after having opened its first location in Charlotte, North Carolina in March 2020.  The Nashville office is instrumental to Titanium’s strategic growth plans to expand into the sizeable and fragmented U.S. Freight Brokerage industry. Additionally, it further positions the Company to capitalize on the broader North American economic recovery.“Opening our Nashville office was a logical and opportunistic decision and evidence that we are executing on our growth strategy to build long-term shareholder value,” said Ted Daniel, President and CEO. “We are looking ahead and ensuring that with strong...

MONTREAL, July 14, 2020 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”) will release its 2020 second quarter results on August 5, 2020 after market close. A conference call and webcast will be held on August 6, 2020 at 8:00 a.m. (Eastern Time) to discuss the results.To participate in the conference call, dial 1-647-427-2309 or 1-866-521-4907 (toll free). A live webcast of the conference call will also be available at www.wsp.com/investors.A presentation of the 2020 second quarter highlights and results will be accessible on August 5, 2020 after market close under the “Investors” section of the WSP website.For those unable to attend, a replay will be available within 24 hours following the call.ABOUT WSPAs one of the world’s leading professional services firms, WSP provides engineering...

MONTRÉAL, 14 juill. 2020 (GLOBE NEWSWIRE) — Groupe WSP Global Inc. (TSX:WSP) (« WSP » ou la « Société ») dévoilera ses résultats financiers du deuxième trimestre 2020 le 5 août 2020 après la fermeture des marchés. Une conférence téléphonique et une webdiffusion audio auront lieu le 6 août 2020 à 8 heures, heure de l’Est, afin de commenter les résultats.Pour participer à la conférence, veuillez composer le 1-647-427-2309 ou le 1-866-521-4907 (sans frais). Une webdiffusion audio en direct sera aussi disponible sur www.wsp.com/investisseurs.Une présentation des résultats et des faits saillants du deuxième trimestre 2020 sera accessible le 5 août 2020 après la fermeture des marchés sous la section « Investisseurs » du site web de WSP.Un enregistrement de la conférence téléphonique sera disponible dans les 24 heures qui suivront celle-ci.À...

OAKVILLE, Ontario, July 14, 2020 (GLOBE NEWSWIRE) — Saint Jean Carbon Inc. (“Saint Jean” or the “Company”) (TSX-V: SJL) (OTCQB: TORVF), a carbon science company engaged in the design and build of green energy storage, green energy creation and green re-creation through the use of carbon materials.  With reference to the News Release dated July 9th, 2019, the Company wishes to announce that it is not proceeding with the previously announced acquisition of Process Research Ortech (“Ortech”).  As of the date of this announcement, the Company has not received documentation that is both required and customary for a fundamental acquisition of this nature.  In addition, the Company believes that the market would not support the proposed transaction during these trying times.  The Company and Ortech are committed to continue working together...

Caris fournira des tests moléculaires d’ADN et d’ARN afin de soutenir l’identification et le recrutement des patients pour l’essai eNRGy de phase 1/2 sur Zenocutuzumab de MerusUTRECHT, Pays-Bas, CAMBRIDGE, Massachusetts, et IRVING, Texas, 14 juill. 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq : MRUS), une société d’oncologie de stade clinique qui développe des anticorps multispécifiques pleine longueur (Biclonics® et Triclonics™), et Caris Life Sciences, un innovateur de premier plan en science moléculaire axé sur l’accomplissement de la promesse de la médecine de précision, ont annoncé aujourd’hui une collaboration visant à détecter les fusions de la néuréguine 1 (NRG1) chez les patients atteints d’un cancer. En vertu de l’accord, Caris a accepté d’effectuer le séquençage...

Caris stellt molekulare DNA- und RNA-Tests zur Verfügung, um die Identifizierung und Teilnahme von Patienten für die Zenocutuzumab-eNRGy-Studie der Phase I/II von Merus zu unterstützenUTRECHT, Niederlande, und CAMBRIDGE, Mass. und IRVING, Texas, July 14, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), ein Unternehmen im Bereich der klinischen Onkologie, das innovative humane multispezifische Antikörper entwickelt (Biclonics® und Triclonics™), und Caris Life Sciences®, ein führender Innovator in der Molekularwissenschaft, der sich darauf konzentriert, das Versprechen der Präzisionsmedizin einzulösen, gaben heute ihre Zusammenarbeit beim Nachweis von Neuregulin 1 (NRG1)-Fusionen bei Krebspatienten bekannt. Im Rahmen der Vereinbarung hat sich Caris bereit erklärt, bei bestimmten Krebspatienten (überwiegend an Pankreaskrebs erkrankte),...

SEATTLE, July 14, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced today the commencement of a proposed underwritten public offering of 8,000,000 shares of its common stock (6,000,000 of which are being offered for sale by Adaptive and 2,000,000 of which are being offered for sale by a selling shareholder). In addition, Adaptive expects to grant the underwriters a 30-day option to purchase up to 1,200,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering...

OTTAWA, July 14, 2020 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY) has acquired EMSEC Solutions Inc. (EMSEC), a boutique firm specializing in radio frequency (RF) emission security and technical surveillance countermeasures.Emissions security relates to the control and prevention of unintentional electrical and electromagnetic emissions that can disclose sensitive or classified information. EMSEC provides technical and professional services including TEMPEST products and other mitigation techniques such as facility zoning (physical distancing, building modifications, separation of IT systems, and other measures). This specialized field is growing as organizations increasingly see a need to protect intellectual property.EMSEC’s customized services include vulnerability assessments, monitoring, training, risk mitigation and countermeasure...